Yigal Nochomovitz
Stock Analyst at Citigroup
(3.09)
# 1,209
Out of 5,156 analysts
323
Total ratings
44.57%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Maintains: Buy | $31 → $35 | $15.81 | +121.38% | 2 | Mar 9, 2026 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $31 → $33 | $26.21 | +25.91% | 5 | Mar 6, 2026 | |
| RCUS Arcus Biosciences | Maintains: Buy | $44 → $45 | $24.30 | +85.19% | 10 | Mar 5, 2026 | |
| ARVN Arvinas | Maintains: Buy | $15 → $18 | $13.92 | +29.31% | 12 | Mar 5, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Neutral | $7 → $8 | $7.60 | +5.26% | 10 | Mar 4, 2026 | |
| SGP SpyGlass Pharma | Initiates: Buy | $42 | $27.14 | +54.75% | 1 | Mar 3, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $51 → $57 | $24.41 | +133.51% | 10 | Mar 2, 2026 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $45 → $44 | $19.60 | +124.49% | 19 | Feb 25, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $16 → $17 | $12.40 | +37.10% | 8 | Feb 24, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $64 → $65 | $34.57 | +88.02% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $336 → $371 | $259.71 | +42.85% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $203 → $204 | $130.91 | +55.83% | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $14 | $6.09 | +129.89% | 17 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2 → $4 | $6.07 | -34.10% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $36 | $22.64 | +59.01% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $60 | $16.87 | +255.66% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $6.60 | +6.06% | 1 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $270 | $213.10 | +26.70% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $24 | $5.24 | +358.02% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $77 | $54.20 | +42.07% | 22 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $1.46 | +310.96% | 11 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $307.76 | +31.60% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $8.42 | +66.27% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $2.00 | +300.00% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $46 | $26.16 | +75.84% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $16.35 | +144.65% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $19.63 | +251.50% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $26.75 | -17.76% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.69 | +12.76% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $12.41 | +319.02% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $17.92 | -60.94% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.58 | +249.51% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $29.44 | +86.82% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $2.89 | +384.43% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $2.23 | -46.19% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.85 | +8.11% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.41 | +47.87% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.79 | -64.16% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $6.89 | +407.98% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $22.71 | +485.65% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.82 | +318.85% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.35 | +640.74% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.65 | +627.27% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $6.16 | - | 14 | Sep 28, 2021 |
EyePoint
Mar 9, 2026
Maintains: Buy
Price Target: $31 → $35
Current: $15.81
Upside: +121.38%
ArriVent BioPharma
Mar 6, 2026
Maintains: Buy
Price Target: $31 → $33
Current: $26.21
Upside: +25.91%
Arcus Biosciences
Mar 5, 2026
Maintains: Buy
Price Target: $44 → $45
Current: $24.30
Upside: +85.19%
Arvinas
Mar 5, 2026
Maintains: Buy
Price Target: $15 → $18
Current: $13.92
Upside: +29.31%
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Neutral
Price Target: $7 → $8
Current: $7.60
Upside: +5.26%
SpyGlass Pharma
Mar 3, 2026
Initiates: Buy
Price Target: $42
Current: $27.14
Upside: +54.75%
Syndax Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $51 → $57
Current: $24.41
Upside: +133.51%
Apellis Pharmaceuticals
Feb 25, 2026
Maintains: Buy
Price Target: $45 → $44
Current: $19.60
Upside: +124.49%
ORIC Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $16 → $17
Current: $12.40
Upside: +37.10%
IDEAYA Biosciences
Feb 19, 2026
Maintains: Buy
Price Target: $64 → $65
Current: $34.57
Upside: +88.02%
Feb 18, 2026
Maintains: Buy
Price Target: $336 → $371
Current: $259.71
Upside: +42.85%
Feb 12, 2026
Maintains: Buy
Price Target: $203 → $204
Current: $130.91
Upside: +55.83%
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $6.09
Upside: +129.89%
Jan 6, 2026
Maintains: Neutral
Price Target: $2 → $4
Current: $6.07
Upside: -34.10%
Jan 6, 2026
Maintains: Buy
Price Target: $33 → $36
Current: $22.64
Upside: +59.01%
Dec 12, 2025
Maintains: Buy
Price Target: $21 → $60
Current: $16.87
Upside: +255.66%
Dec 10, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $6.60
Upside: +6.06%
Dec 9, 2025
Initiates: Buy
Price Target: $270
Current: $213.10
Upside: +26.70%
Nov 14, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $5.24
Upside: +358.02%
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $54.20
Upside: +42.07%
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.46
Upside: +310.96%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $307.76
Upside: +31.60%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $8.42
Upside: +66.27%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $2.00
Upside: +300.00%
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $26.16
Upside: +75.84%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $16.35
Upside: +144.65%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $19.63
Upside: +251.50%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $26.75
Upside: -17.76%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.69
Upside: +12.76%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $12.41
Upside: +319.02%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $17.92
Upside: -60.94%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.58
Upside: +249.51%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $29.44
Upside: +86.82%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $2.89
Upside: +384.43%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $2.23
Upside: -46.19%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.85
Upside: +8.11%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.41
Upside: +47.87%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.79
Upside: -64.16%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $6.89
Upside: +407.98%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $22.71
Upside: +485.65%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.82
Upside: +318.85%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.35
Upside: +640.74%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.65
Upside: +627.27%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $6.16
Upside: -